A review by Ruhwald, et al., showed variability of findings on the potential use of IP-10 as a biomarker in diagnosis of TB disease, as being influenced by differences in dilution of samples, type of samples used, assays to measure IP-10, and diagnostic cut-offs used [34]. This evidence concerns the gene CXCL10 and tuberculosis.